Recurrent genetic alterations in AML-EMD, including complex karyotypes and pathogenic mutations in TP53, JAK2, and GATA1 mutations found in AML-EMD, were associated with early erythroid and MEP/megakaryocytic progenitor differentiation states. This evidence concerns the gene GATA1 and acute myeloid leukemia.